Back to Top
Go Back
Journal Photo for ImmunoTargets and Therapy
Peer reviewed only Open Access

ImmunoTargets and Therapy (IT)

Publisher : Taylor & Francis
Biology pathophysiology therapeutic and prophylactic vaccines
e-ISSN 2253-1556
Issue Frequency Continuously
Impact Factor 6.2
Est. Year 2012
Mobile 4402080520500
DOI YES
Language English
APC YES
Impact Factor Assignee GOOGLE SCHOLAR
Email enquiries@taylorandfrancis.com

Journal Descriptions

ImmunoTargets and Therapy is an international journal that aims to present and publish basic and clinical research on the aspects of immunology in health and disease. ImmunoTargets and Therapy is primarily focused on the immunological basis of disease and explores the evidence behind new and existing immunotherapies in terms of improving outcomes and, importantly, will seek to define their usage in terms of ultimate uptake and acceptance by the patient and health care professional. Specific Topics covered in this journal include: Biology and pathophysiology of the immune system in health and disease Immunological basis and immunological markers of diseases Potential targets for immune based therapy including therapeutic and prophylactic vaccines Novel and improved targets for immunodiagnostics and immunomonitoring Treatment protocols to improve management of patient with immune-mediated diseases Impact of management programs and new therapeutic agents Protocols on patient perspectives such as quality of life, adherence, and satisfaction

ImmunoTargets and Therapy (IT) is :-

  • International, Peer-Reviewed, Open Access, Refereed, Biology, pathophysiology, therapeutic and prophylactic vaccines, diseases, Treatment protocols, improve management, patient perspectives , Online , Continuously Journal

  • UGC Approved, ISSN Approved: P-ISSN E-ISSN: 2253-1556, Established: 2012, Impact Factor: 6.2
  • Provides Crossref DOI
  • Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE

Indexing